Literature DB >> 25752684

Chloroquine and Hydroxychloroquine Increase Retinal Pigment Epithelial Layer Permeability.

Nicoline M Korthagen1, Jeroen Bastiaans1, Jan C van Meurs2,3, Kiki van Bilsen4, P Martin van Hagen1,2,4, Willem A Dik1.   

Abstract

Antimalarials chloroquine (CQ) and hydroxychloroquine (HCQ) are widely used as antiinflammatory drugs, but side effects include retinopathy and vision loss. The objective of this study was to examine the effect of CQ and HCQ on the barrier integrity of retinal pigment epithelial (RPE) cell monolayers in vitro. Permeability of ARPE-19 cell monolayers was determined using Fluorescein isothiocyanate (FITC)-labeled dextran. The influence of CQ and HCQ on cell death and the expression tight junction molecules was examined. CQ and HCQ significantly increased ARPE-19 monolayer permeability after 3 and 18 h, respectively, and enhanced mRNA levels for claudin-1 and occludin. Cytotoxicity was only observed after 18 h exposure. Thus, CQ and HCQ rapidly enhance RPE barrier permeability in vitro, independent of cytotoxicity or loss of zonula occludens-1, claudin-1, and occludin expression. Our findings suggest that CQ/HCQ-induced permeability of the RPE layer may contribute to blood-retinal barrier breakdown in case of CQ/HCQ-induced retinopathy.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Transwell; barrier function; chloroquine; hydroxychloroquine; retinal pigment epithelial cell; tight-junctions

Mesh:

Substances:

Year:  2015        PMID: 25752684     DOI: 10.1002/jbt.21696

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  10 in total

Review 1.  [Progressive maculopathy despite discontinuation of chloroquine treatment-multimodal imaging and review of the literature].

Authors:  A Rickmann; S Al-Nawaiseh; L Ramirez; S Röhrig; M Ladewig; P Szurman; G Szurman
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

2.  Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.

Authors:  Mehmet Bulut; Melih Akıdan; Onursal Gözkaya; Muhammet Kazım Erol; Ayşe Cengiz; Hasan Fatih Çay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-29       Impact factor: 3.117

3.  MERCI: a machine learning approach to identifying hydroxychloroquine retinopathy using mfERG.

Authors:  Faisal Habib; Huaxiong Huang; Arvind Gupta; Tom Wright
Journal:  Doc Ophthalmol       Date:  2022-06-22       Impact factor: 1.854

Review 4.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

Review 5.  Hydroxychloroquine retinopathy.

Authors:  I H Yusuf; S Sharma; R Luqmani; S M Downes
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

6.  Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report.

Authors:  Gang Wang; Ning Zhuo; Zheng Liao; Wei Qi; Feng Tian; Zhenhua Wen; Jingyang Li
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

7.  Hydroxychloroquine for treatment of rheumatoid arthritis: multifocal electroretinogram and laser flare-cell photometry study.

Authors:  Stefano Sebastiani; Michela Fresina; Mauro Cellini; Emilio C Campos
Journal:  Clin Ophthalmol       Date:  2017-04-11

Review 8.  Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities.

Authors:  Romain Muller
Journal:  Rheumatol Int       Date:  2021-04-24       Impact factor: 2.631

9.  Extreme Interocular Asymmetry in an Atypical Case of a Hydroxychloroquine-Related Retinopathy.

Authors:  Gabriel Hallali; Zari Seyed; Anne-Véronique Maillard; Karima Drine; Laurence Lamour; Céline Faure; Isabelle Audo
Journal:  Medicina (Kaunas)       Date:  2022-07-21       Impact factor: 2.948

10.  Docetaxel-induced maculopathy possibly potentiated by concurrent hydroxychloroquine use.

Authors:  Abdelrahman M Elhusseiny; Nidhi Relhan; William E Smiddy
Journal:  Am J Ophthalmol Case Rep       Date:  2019-09-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.